A. All-cause mortality | |||||||
---|---|---|---|---|---|---|---|
Phosphate categories | Number of patients at risk | Number of events | Follow-up time (months) | Crude incidence rate | 95 % confidence interval | P value* | |
<0.90 mmol/L | 422 | 39 | 18.89 | (10.94–32.46) | 50.82 | (34.87–66.77) | <0.001 |
0.90–1.09 mmol/L | 912 | 96 | 21.90 | (11.47–33.66) | 54.38 | (43.50–65.26) | Ref. |
1.10–1.29 mmol/L | 1004 | 130 | 21.68 | (11.37–34.29) | 67.48 | (55.88–79.08) | <0.001 |
1.30–1.49 mmol/L | 435 | 64 | 20.30 | (11.63–32.23) | 78.90 | (59.57–98.23) | <0.001 |
≥1.50 mmol/L | 177 | 46 | 17.58 | (6.85–32.00) | 154.94 | (110.17–199.72) | <0.001 |
Total | 2950 | 375 | 20.57 | (11.14–33.48) | 67.36 | (60.54–74.18) |  |
B. Cardiovascular mortality | |||||||
Phosphate categories | Number of Patients at risk | Number of Events | Follow-up time (months) | Crude Incidence Rate | 95 % Confidence Interval | P value* | |
<0.90 mmol/L | 422 | 6 | 18.89 | (10.94–32.46) | 7.82 | (1.56–14.07) | 0.003 |
0.90–1.09 mmol/L | 912 | 18 | 21.90 | (11.47–33.66) | 10.20 | (5.49–14.91) | Ref. |
1.10–1.29 mmol/L | 1004 | 24 | 21.68 | (11.37–34.29) | 12.46 | (7.47–17.44) | 0.037 |
1.30–1.49 mmol/L | 435 | 6 | 20.30 | (11.63–32.23) | 7.40 | (1.48–13.32) | <0.001 |
≥1.50 mmol/L | 177 | 13 | 17.58 | (6.85–32.00) | 43.79 | (19.98–67.59) | <0.001 |
Total | 2950 | 67 | 20.57 | (11.14–33.48) | 12.03 | (9.15–14.92) |  |
C. Renal Replacement Therapy | |||||||
Phosphate categories | Number of Patients at risk | Number of Events | Follow-up time (months) | Crude Incidence Rate | 95 % Confidence Interval | P value* | |
<0.90 mmol/L | 422 | 4 | 18.79 | (10.93–32.36) | 5.24 | (0.10–10.38) | <0.001 |
0.90–1.09 mmol/L | 912 | 14 | 21.65 | (11.18–33.63) | 8.00 | (3.81–12.18) | Ref. |
1.10–1.29 mmol/L | 1004 | 21 | 20.91 | (11.07–33.64) | 11.05 | (6.32–15.78) | 0.004 |
1.30–1.49 mmol/L | 435 | 26 | 19.42 | (11.07–31.27) | 33.26 | (20.48–46.05) | <0.001 |
≥1.50 mmol/L | 177 | 33 | 13.63 | (4.78–28.09) | 133.96 | (88.25–179.67) | <0.001 |
Total | 2950 | 98 | 19.88 | (10.68–32.92) | 18.01 | (14.44–21.75) |  |